发明名称 <i>O</i>-GlcNAc transferase inhibitors and uses thereof
摘要 The present invention provides inhibitors of O-GIcNAc transferase. Typically, the inhibitors are quinolinone-6-sulfonamides. The invention also provides pharmaceutical compositions thereof and methods for using the same in diabetes and complications thereof, neurodegenerative diseases, cancers, autoimmune diseases, and inflammatory diseases.
申请公布号 US8957075(B2) 申请公布日期 2015.02.17
申请号 US201013375036 申请日期 2010.06.01
申请人 President and Fellows of Harvard College 发明人 Kahne Suzanne Walker;Lazarus Michael Block;Gross Benjamin J.
分类号 A61K31/496;A61K31/4709;A61K31/4725;C07D401/12;C07D401/14;C07D409/14;C07D215/36;C07D417/12;C07D405/12 主分类号 A61K31/496
代理机构 Wolf, Greenfield &amp; Sacks, P.C. 代理人 Wolf, Greenfield &amp; Sacks, P.C. ;Baker C. Hunter
主权项 1. A compound of formula (I):or a pharmaceutically acceptable salt thereof, wherein denotes a single or double bond; R1 is cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted, branched or unbranched arylalkyl; or substituted or unsubstituted, branched or unbranched heteroarylalkyl; R2 and R3 are independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted, branched or unbranched arylalkyl; substituted or unsubstituted, branched or unbranched heteroarylalkyl; —C(═O)RB; —SORB; —SO2RB; or —C(RB)3; wherein each occurrence of RB is independently hydrogen; halogen; a protecting group; aliphatic; heteroaliphatic; acyl; aryl; heteroaryl; hydroxyl; alkoxy; aryloxy; amino; alkylamino; dialkylamino; or heteroaryloxy; or R2 and R3 may optionally be taken together with the intervening nitrogen to form a saturated or unsaturated, substituted or unsubstituted heterocyclic moiety; R4 is hydrogen, C1-6 aliphatic, or a protecting group; R5 is hydrogen, C1-6 aliphatic, or a protecting group; R6 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted, branched or unbranched aryl; substituted or unsubstituted, branched or unbranched heteroaryl; —ORF; —C(═O)RF; —CO2RF; —C(═O)N(RF)2; —CN; —SCN; —SRF; —SORF; —SO2RF; —NO2; —N(RF)2; —NHC(O)RF; or —C(RF)3; wherein each occurrence of RF is independently hydrogen; halogen; a protecting group; aliphatic; heteroaliphatic; acyl; aryl moiety; heteroaryl; hydroxy; alkoxy; aryloxy; alkylthioxy; arylthioxy; amino; alkylamino; dialkylamino; heteroaryloxy; or heteroarylthioxy; and n is 0, 1, 2, or 3; wherein the compound of formula (I) is not one of the following:
地址 Cambridge MA US